1. Home
  2. IH vs PLRX Comparison

IH vs PLRX Comparison

Compare IH & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iHuman Inc.

IH

iHuman Inc.

N/A

Current Price

$1.32

Market Cap

70.5M

Sector

Real Estate

ML Signal

N/A

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

HOLD

Current Price

$1.08

Market Cap

65.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IH
PLRX
Founded
1996
2015
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
70.5M
65.6M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
IH
PLRX
Price
$1.32
$1.08
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
$2.67
AVG Volume (30 Days)
2.9K
408.1K
Earning Date
03-31-2026
05-06-2026
Dividend Yield
5.88%
N/A
EPS Growth
N/A
29.97
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$7.30
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.28
$1.02
52 Week High
$3.16
$1.95

Technical Indicators

Market Signals
Indicator
IH
PLRX
Relative Strength Index (RSI) 43.54 47.32
Support Level $1.28 N/A
Resistance Level $1.45 $1.27
Average True Range (ATR) 0.03 0.03
MACD 0.00 0.00
Stochastic Oscillator 22.00 55.56

Price Performance

Historical Comparison
IH
PLRX

About IH iHuman Inc.

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. All of the groups revenue is generated from Chinese Mainland.

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

Share on Social Networks: